pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
OM-301
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Oncolyze Inc
0 catalysts
OMEGAVEN
OMEGAVEN (FISH OIL)
FRESENIUS KABI USA
0 catalysts
OMIDRIA
OMIDRIA (PHENYLEPHRINE AND KETOROLAC)
RAYNER SURGICAL
0 catalysts
Phase 2
OMO-1
Solid Tumor
DeuterOncology NV
0 catalysts
← prev
page 117 of 231
next →
131
Pain89
Neurology1
Phase 1
OMS-527
Substance (Drug) Abuse
$OMEROMEROS CORP
0 catalysts
Phase 2
ONC-841
Colorectal Cancer
OncoC4 Inc
0 catalysts
Phase 2
ONO-2020
Alzheimer's Disease
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 2
ONO-2808
Multiple System Atrophy (Multi-System Degeneration)
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 1
ONO-2910
Diabetic Neuropathy
Ono Pharmaceutical Co Ltd
0 catalysts
Phase 1
OP-3136
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
$OLMAOlema Pharmaceuticals, Inc.
0 catalysts
Preclinical
OPB-171775
Gastrointestinal Stromal Tumor (GIST)
$BDRXBiodexa Pharmaceuticals Plc
0 catalysts
Phase 2
OPC-1
Acute Spinal Cord Injury
5-hydroxytryptamine receptor 2AD(2) dopamine receptor
$LCTXLineage Cell Therapeutics, Inc.
0 catalysts
Phase 1
OPC-214870
Epilepsy
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 2
OPCT-001
Retinal Degeneration
BlueRock Therapeutics LP
0 catalysts
Phase 2
OPF-310
Type 1 Diabetes (Juvenile Diabetes)
Otsuka Pharmaceutical Co Ltd
0 catalysts
Phase 2
OPGx-BEST1
Macular Degeneration
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPGx-CNGB1
Retinitis Pigmentosa (Retinitis)
$IRDOpus Genetics, Inc.
0 catalysts
Phase 3
OPGx-LCA5
Leber Congenital Amaurosis (LCA)
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPGx-RDH12
Leber Congenital Amaurosis (LCA)
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPGx-RHO
Retinitis Pigmentosa (Retinitis)
$IRDOpus Genetics, Inc.
0 catalysts
Preclinical
OPK-88006
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$OPKOPKO HEALTH, INC.
0 catalysts
Phase 1
OPL-009
Hypertension
Overseas Pharmaceuticals Ltd
0 catalysts
Phase 3
OPL-015
Pain
Overseas Pharmaceuticals Ltd
0 catalysts
Phase 1
OPN-6602
Refractory Multiple Myeloma
Opna Bio SA
0 catalysts
Preclinical
OPTF-01
Glioblastoma Multiforme (GBM)
Optieum Biotechnologies Inc
0 catalysts
OPTIONELLE
OPTIONELLE (LEVONORGESTREL TABLET, 1.5 MG)
NAARI PTE
0 catalysts
OPTIRAY 320
OPTIRAY 320 (IOVERSOL)
LIEBEL-FLARSHEIM
0 catalysts
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES
OPTISON PERFLUTREN PROTEIN-TYPE A MICROSPHERES (HUMAN ALBUMIN MICROSPHERES AND PERFLUTREN)
GE HEALTHCARE
0 catalysts
Preclinical
OQL-036
Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome)
OnQuality Pharmaceuticals LLC
0 catalysts
Preclinical
OQY-8811
Multiple Myeloma (Kahler Disease)
Oqory Inc
0 catalysts